Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.

Míreanna comhchosúla

• Low-dose rapamycin treatment increases the ability of human regulatory T cells to inhibit transplant arteriosclerosis in vivo.
  de réir: Hester, J, et al.
  Foilsithe / Cruthaithe: (2012)
• In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells.
  de réir: Nadig, SN, et al.
  Foilsithe / Cruthaithe: (2010)
• Inflammatory Ly-6Chi monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients
  de réir: Schiopu, A, et al.
  Foilsithe / Cruthaithe: (2012)
• Inflammatory Ly-6C(hi) monocytes play an important role in the development of severe transplant arteriosclerosis in hyperlipidemic recipients.
  de réir: Schiopu, A, et al.
  Foilsithe / Cruthaithe: (2012)
• Ex vivo expanded human treg inhibit the development of transplant arteriosclerosis in a humanized in vivo model
  de réir: Nadig, SN, et al.
  Foilsithe / Cruthaithe: (2008)